PURPOSE: Accurately classifying inflammatory bowel disease (IBD) type in pediatric patients may impact medical decision-making, direct therapy, and improve outcomes. METHODS: This was a prospective cohort study evaluating classification of IBD and patient management with use of capsule endoscopy in pediatric patients with suspected or known IBD. Treating physicians completed a questionnaire before and after capsule endoscopy (CE) assessing clinical suspicion of Crohn's disease (CD) diagnosis, patient management decisions, and perceived impact of CE findings. RESULTS: Eighteen subjects [11F/7M, mean age 13.8 (± 2.5) years], 4 previously diagnosed with CD, 4 with ulcerative or indeterminate colitis (UC/IC), and 10 "suspected" to have IBD were included. Following CE, 2 of 4 (50%) UC/IC patients were reclassified as having small bowel CD. In the 4 subjects with known CD, 2 (50%) had CE evidence of more proximal small bowel mucosal disease than previously recognized. In the 10 subjects with "suspected" IBD, 8 (80%) had SB ulcerations leading to a definitive diagnosis of CD. Treating physicians reported CE helped diagnosing CD in 15 of 18 (83.3%) subjects and impacted medical decision-making in 13 of 18 (72.2%), leading to a change in medical management in 14 of 18 (77.8%). CONCLUSIONS: In "suspected" pediatric IBD, CE often leads to a definitive diagnosis of CD. CE can lead to reclassification of IBD from UC/IC to CD and previously diagnosed CD patients may have a more significant burden of small bowel disease. These data may help integrate CE in evaluating IBD patients, lead to more targeted medical management changes and improve outcomes.
PURPOSE: Accurately classifying inflammatory bowel disease (IBD) type in pediatric patients may impact medical decision-making, direct therapy, and improve outcomes. METHODS: This was a prospective cohort study evaluating classification of IBD and patient management with use of capsule endoscopy in pediatric patients with suspected or known IBD. Treating physicians completed a questionnaire before and after capsule endoscopy (CE) assessing clinical suspicion of Crohn's disease (CD) diagnosis, patient management decisions, and perceived impact of CE findings. RESULTS: Eighteen subjects [11F/7M, mean age 13.8 (± 2.5) years], 4 previously diagnosed with CD, 4 with ulcerative or indeterminate colitis (UC/IC), and 10 "suspected" to have IBD were included. Following CE, 2 of 4 (50%) UC/IC patients were reclassified as having small bowel CD. In the 4 subjects with known CD, 2 (50%) had CE evidence of more proximal small bowel mucosal disease than previously recognized. In the 10 subjects with "suspected" IBD, 8 (80%) had SB ulcerations leading to a definitive diagnosis of CD. Treating physicians reported CE helped diagnosing CD in 15 of 18 (83.3%) subjects and impacted medical decision-making in 13 of 18 (72.2%), leading to a change in medical management in 14 of 18 (77.8%). CONCLUSIONS: In "suspected" pediatric IBD, CE often leads to a definitive diagnosis of CD. CE can lead to reclassification of IBD from UC/IC to CD and previously diagnosed CDpatients may have a more significant burden of small bowel disease. These data may help integrate CE in evaluating IBD patients, lead to more targeted medical management changes and improve outcomes.
Authors: Stuart L Triester; Jonathan A Leighton; Grigoris I Leontiadis; Suryakanth R Gurudu; David E Fleischer; Amy K Hara; Russell I Heigh; Arthur D Shiff; Virender K Sharma Journal: Am J Gastroenterol Date: 2006-05 Impact factor: 10.864
Authors: Jonathan A Leighton; Ian M Gralnek; Randel E Richner; Michael J Lacey; Frank J Papatheofanis Journal: World J Gastroenterol Date: 2009-12-07 Impact factor: 5.742
Authors: William S Mow; Simon K Lo; Stephan R Targan; Marla C Dubinsky; Leo Treyzon; Maria T Abreu-Martin; Konstantinos A Papadakis; Eric A Vasiliauskas Journal: Clin Gastroenterol Hepatol Date: 2004-01 Impact factor: 11.382
Authors: Stanley A Cohen; Ian M Gralnek; Hagit Ephrath; Larry Saripkin; William Meyers; Olga Sherrod; Angela Napier; Tamara Gobin Journal: J Pediatr Gastroenterol Nutr Date: 2008-07 Impact factor: 2.839
Authors: Gian Luigi de' Angelis; Fabiola Fornaroli; Nicola de' Angelis; Barbara Magiteri; Barbara Bizzarri Journal: Am J Gastroenterol Date: 2007-08 Impact factor: 10.864
Authors: Ioannis V Mitselos; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos Journal: World J Gastrointest Endosc Date: 2015-06-10
Authors: Salvatore Oliva; Stanley A Cohen; Giovanni Di Nardo; Gianfranco Gualdi; Salvatore Cucchiara; Emanuele Casciani Journal: World J Gastroenterol Date: 2014-11-28 Impact factor: 5.742
Authors: Marisol Luján-Sanchis; Laura Sanchis-Artero; Laura Larrey-Ruiz; Laura Peño-Muñoz; Paola Núñez-Martínez; Génesis Castillo-López; Lara González-González; Carlos Boix Clemente; Cecilia Albert Antequera; Ana Durá-Ayet; Javier Sempere-Garcia-Argüelles Journal: World J Gastrointest Endosc Date: 2016-09-16
Authors: José María Remes-Troche; Victoria Alejandra Jiménez-García; Josefa María García-Montes; Pedro Hergueta-Delgado; Federico Roesch-Dietlen; Juan Manuel Herrerías-Gutiérrez Journal: Clin Exp Gastroenterol Date: 2013-09-18
Authors: Federico Argüelles-Arias; Juan Rodríguez-Oballe; Calixto Duarte-Chang; Luisa Castro-Laria; Josefa María García-Montes; Angel Caunedo-Álvarez; Juan Manuel Herrerías-Gutiérrez Journal: Gastroenterol Res Pract Date: 2014-03-11 Impact factor: 2.260